| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/28/2002 | WO2002016439A2 Novel nucleic acids and polypeptides |
| 02/28/2002 | WO2002016427A1 Crystal structure of a ras-pi3k complex |
| 02/28/2002 | WO2002016415A2 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | WO2002016397A2 Haplotypes of the lipg gene |
| 02/28/2002 | WO2002016386A1 Human telomerase rna elements |
| 02/28/2002 | WO2002016377A2 Human cytidine monophosphate (cmp) kinase cdna |
| 02/28/2002 | WO2002016365A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/28/2002 | WO2002015927A1 High mannose proteins and methods of making high mannose proteins |
| 02/28/2002 | WO2002015918A2 Method and compositions for promoting osteogenesis |
| 02/28/2002 | WO2002015681A1 Transgenic mammals |
| 02/28/2002 | WO2002015680A1 Type iii allergic inflammation model animal |
| 02/28/2002 | WO2001085967A3 Corynebacterium glutamicum strain with enhanced secretion activity |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001083763A3 Phytase polypeptides |
| 02/28/2002 | WO2001083676A3 A novel polypeptide human strip-riched phosphatase 10 and the polynucleotide encoding said polypeptide |
| 02/28/2002 | WO2001081595A3 Human caspase-14 compositions |
| 02/28/2002 | WO2001081537A3 A NOVEL POLYPEPTIDE, DNA REPLICATION FACTOR C(A1) 37Kd HUMAN SUB-UNIT 49, AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 02/28/2002 | WO2001081534A3 A NOVEL POLYPEPTIDE, A HUMAN 2Fe-2S OXYDOREDUCTASE 12 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 02/28/2002 | WO2001079446A3 Materials and methods relating to lipid metabolism |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001077305A3 Variants of the human amp-activated protein kinase gamma 3 subunit |
| 02/28/2002 | WO2001073083A3 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |
| 02/28/2002 | WO2001073043A3 32451, a human ubiquitin conjugating enzyme-like molecule and uses thereof |
| 02/28/2002 | WO2001072967A3 Promoter sequence of 3-phosphoglycerate kinase gene 2 of rhizopus oryzae and its use |
| 02/28/2002 | WO2001072963A3 Novel human uridine kinase |
| 02/28/2002 | WO2001070997A3 Regulation of human leucine aminopeptidase-like enzyme |
| 02/28/2002 | WO2001068845A3 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof |
| 02/28/2002 | WO2001060986A3 Esterase enzymes having selective activity |
| 02/28/2002 | WO2001058936A3 Constructs for delivery of therapeutic agents to neuronal cells |
| 02/28/2002 | WO2001057188A3 Novel nucleic acids and polypeptides |
| 02/28/2002 | WO2001055327A3 Nucleic acids, proteins, and antibodies |
| 02/28/2002 | WO2001051639A3 Everninomicin biosynthetic genes |
| 02/28/2002 | WO2001038500A3 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same |
| 02/28/2002 | WO2001036656B1 A complex between hyaluronic acid and a biomolecule and its use |
| 02/28/2002 | WO2001031029A3 Human sphingosine kinase gene |
| 02/28/2002 | WO2001027284A3 Recombinant megalomicin biosynthetic genes and uses thereof |
| 02/28/2002 | WO2001025469A3 Method for preparing steroids modified by yeast fermentation |
| 02/28/2002 | WO2000040569A9 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 02/28/2002 | US20020026658 Adjustment of plant metabolism |
| 02/28/2002 | US20020026657 Genetic control of fruit ripening |
| 02/28/2002 | US20020026654 Expression vectors for use as diagnostic tools in the classification of gene activity; for use in treatment and prevention of allergies, dermatitis, arthritis, congestion, infection, anaphylaxis and sudden infant death syndrome |
| 02/28/2002 | US20020026653 Expression vector for use in classification of gene activity and prevention and treatment defects associated with enzymatic disorders |
| 02/28/2002 | US20020026652 Transgenic mice containing cGMP phosphodiesterase gene disruptions |
| 02/28/2002 | US20020026650 Migrating nucleotide sequences; for as diagnostic tools in the detection of migrating genomic sequences |
| 02/28/2002 | US20020026046 Mixing composition with reducing agent, heating; wherein any ribonucleases in composition are substantially inactivated or inhibited |
| 02/28/2002 | US20020025980 Single morphic forms of metalloproteinase inhibitors |
| 02/28/2002 | US20020025942 Novel tau/neurofilament protein kinases |
| 02/28/2002 | US20020025935 Antiinflammatory agents; autoimmune diseases; central nervous system disorders |
| 02/28/2002 | US20020025931 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
| 02/28/2002 | US20020025577 Eukaryotic gene expression cassette and uses thereof |
| 02/28/2002 | US20020025570 Peptides; for use as tools in human therapeutics and diagnostic testing |
| 02/28/2002 | US20020025569 Enzymatic polypeptide; for use as a tool in the diagnosis of abberant protein degradation, cell differentiation and proliferation |
| 02/28/2002 | US20020025566 From dipeptides |
| 02/28/2002 | US20020025557 32447, a novel human acyltransferase and uses thereof |
| 02/28/2002 | US20020025550 Methods for producing highly phosphorylated lysosomal hydrolases |
| 02/28/2002 | US20020025549 Synthesis and recovery of aspartame involving enzymatic deformylation step |
| 02/28/2002 | US20020025540 Isolation of functionally active gamma- secretase protein complex and methods for detection of activity and Inhibitors thereof |
| 02/28/2002 | US20020025517 Methods and compositions for cellular and metabolic engineering |
| 02/28/2002 | US20020025515 Inviable virus particles as scaffolds for constructing flexible detection systems |
| 02/28/2002 | US20020025456 Process for producing electrical energy with the aid of a fuel cell |
| 02/28/2002 | US20020025305 Cell-cycle regulatory proteins, and uses related thereto |
| 02/28/2002 | CA2708605A1 Nucleotide sequences of a new class of diverged delta-9 stearoyl-acp desaturase genes |
| 02/28/2002 | CA2421062A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | CA2421059A1 Constructs and their use in metabolic pathway engineering |
| 02/28/2002 | CA2420490A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/28/2002 | CA2420487A1 Novel human proteases and polynucleotides encoding the same |
| 02/28/2002 | CA2420328A1 Synthetic nucleic acid molecule compositions and methods of preparation |
| 02/28/2002 | CA2420325A1 Plant polynucleotides encoding novel prenyl proteases |
| 02/28/2002 | CA2420257A1 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | CA2419915A1 New sequences |
| 02/28/2002 | CA2419896A1 Subtilase enzymes |
| 02/28/2002 | CA2419872A1 Identification of a human n-terminal acetyltransferase gene |
| 02/28/2002 | CA2419810A1 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | CA2418461A1 Method and compositions for promoting osteogenesis |
| 02/28/2002 | CA2418300A1 A novel aminopeptidase produced from aspergillus niger |
| 02/28/2002 | CA2417787A1 Lipid metabolism enzymes |
| 02/28/2002 | CA2415182A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/27/2002 | EP1182263A1 Process for detecting threonine/serine kinase activity |
| 02/27/2002 | EP1182260A1 Process for producing amide compounds |
| 02/27/2002 | EP1182259A1 Pyruvate:NADP+ oxidoreductase and uses thereof |
| 02/27/2002 | EP1182258A1 Mutants of the factor VII activating protease and methods for their detection |
| 02/27/2002 | EP1182257A1 Nucleic acids encoding dihydroflavonol 4-reductase with altered specificity and uses thereof |
| 02/27/2002 | EP1182253A2 Method for improving the thermostability of proteins |
| 02/27/2002 | EP1182251A1 Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of IkB |
| 02/27/2002 | EP1182213A1 Hybrid enzyme and use thereof |
| 02/27/2002 | EP1181393A2 CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L11/GTPASE ACTIVATING REGION rRNA AND USES THEREOF |
| 02/27/2002 | EP1181391A2 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents |
| 02/27/2002 | EP1181390A1 27 human secreted proteins |
| 02/27/2002 | EP1181379A1 Method for reducing phytate in canola meal using genetic manipulation involving myo-inositol 1-phosphate synthase gene |
| 02/27/2002 | EP1181377A2 Protein conjugates, methods, vectors, proteins and dna for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates |
| 02/27/2002 | EP1181376A2 Gene construct for prodrug activation encoding a heterologous, glycosylphophatidylinositol-modified carboxypeptidase g2 and a cell surface targeting signal peptide |
| 02/27/2002 | EP1181375A2 Sulfohydrolases, corresponding amino acid and nucleotide sequences, sulfohydrolase preparations, processes, and products thereof |
| 02/27/2002 | EP1181374A1 Novel murine and human kinases |
| 02/27/2002 | EP1181373A1 Delta6-acetylenase and delta6-desaturase from ceratodon purpureus |
| 02/27/2002 | EP1181356A2 Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration |
| 02/27/2002 | EP1181291A2 Dna methyltransferase inhibitors |
| 02/27/2002 | EP1181047A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 02/27/2002 | EP1181046A2 10-formyltetrahydrofolate dehydrogenase as therapeutical agent |